Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut-Lung Axis in Cystic Fibrosis
Courtney E. Price, George A. O’Toole
Journal of Bacteriology (2021) Vol. 203, Iss. 20
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Intestinal Bacteroides modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis
Courtney E. Price, Rebecca A. Valls, Alexis R. Ramsey, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 16
Probiotics: Protecting Our Health from the Gut
Gael Urait Varela-Trinidad, Carolina Domínguez-Díaz, Karla Solórzano-Castanedo, et al.
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1428-1428
Open Access | Times Cited: 47
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future
Christina S. Thornton, Michael D. Parkins
Seminars in Respiratory and Critical Care Medicine (2023) Vol. 44, Iss. 02, pp. 269-286
Open Access | Times Cited: 30
Respiratory and Intestinal Microbiota in Pediatric Lung Diseases—Current Evidence of the Gut–Lung Axis
Sebastian Stricker, Torsten Hain, Cho‐Ming Chao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6791-6791
Open Access | Times Cited: 33
Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome
Vidushi Aggarwal, Sushant Sunder, Smita Rastogi Verma
Folia Microbiologica (2022) Vol. 67, Iss. 6, pp. 811-824
Open Access | Times Cited: 31
Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation
Christina S. Thornton, Nicole Acosta, Michael G. Surette, et al.
Journal of the Pediatric Infectious Diseases Society (2022) Vol. 11, Iss. Supplement_2, pp. S13-S22
Open Access | Times Cited: 30
SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1
Budhadev Baral, Vaishali Saini, A Tandon, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1596-1617
Closed Access | Times Cited: 18
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Francesco Amati, Anna Stainer, Marco Mantero, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 977-977
Open Access | Times Cited: 25
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome
Ryan Marsh, Claudio Dos Santos, Liam Hanson, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 15
Development of the intestinal microbiome in cystic fibrosis in early life
Courtney E. Price, Thomas H. Hampton, Rebecca Valls, et al.
mSphere (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 13
Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
Seth A. Reasoner, Rachel Bernard, Adam Waalkes, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 5
Diet and the gut-lung axis in cystic fibrosis – direct & indirect links
Isabelle McKay, Josie van Dorst, Tamarah Katz, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis
José A. Caparrós‐Martín, Montserrat Saladié, S. Patricia Agudelo-Romero, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice
Anna Bertolini, Mytien Nguyen, Syeda Andleeb Zehra, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 429-440
Closed Access | Times Cited: 4
Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis
Adrian J. Verster, Paige Salerno, Rebecca Valls, et al.
mBio (2025)
Open Access
Activation of Sirt1 by acetate alleviates silicofibrosis: Contribution of the gut microbiota
Weiliang Zhang, Xue‐Jie Qi, Mingming Han, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117969-117969
Open Access
Spontaneous lung colonization in the cystic fibrosis rat model is linked to gastrointestinal obstruction
Mikayla Murphree-Terry, Johnathan D. Keith, Ashley M. Oden, et al.
mBio (2025)
Open Access
Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis
Hillary S. Hayden, Maria T. Nelson, Sydney E. Ross, et al.
Pediatric Pulmonology (2025) Vol. 60, Iss. 3
Open Access
Effectiveness of Probiotics, Prebiotics, and Symbiotic Supplementation in Cystic Fibrosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials
Freiser Eceomo Cruz Mosquera, Claudia Lorena Perlaza, Anisbed Naranjo Rojas, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 489-489
Open Access
The Gut–Liver Axis in Pediatric Liver Health and Disease
Stephanie L. Rager, Melody Y. Zeng
Microorganisms (2023) Vol. 11, Iss. 3, pp. 597-597
Open Access | Times Cited: 10
Distinct enterotypes and dysbiosis: unraveling gut microbiota in pulmonary and critical care medicine inpatients
Naijian Li, Guiyan Tan, Zhiling Xie, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Probiotics Administration in Cystic Fibrosis: What Is the Evidence?
Susanna Esposito, Ilaria Testa, Elena Mariotti Zani, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3160-3160
Open Access | Times Cited: 13
Persistent delay in maturation of the developing gut microbiota in infants with cystic fibrosis
Paige Salerno, Adrian J. Verster, Rebecca Valls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Plant-Based Dietary Fibers and Polysaccharides as Modulators of Gut Microbiota in Intestinal and Lung Inflammation: Current State and Challenges
Yu Shen, Mingming Song, Shihao Wu, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3321-3321
Open Access | Times Cited: 7
Lung-Directed Bacteriotherapy in Cystic Fibrosis: Could It Be an Option?
Giovanna Batoni, Giuseppantonio Maisetta, Esingül Kaya, et al.
Antibiotics (2022) Vol. 11, Iss. 3, pp. 326-326
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top